Discussion on: Adapting to Newer Hemostatic Agent Emicizumab for Major Surgery in Hemophilia A: An Experience in Neurosurgery for an Infant

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title

Adapting to Newer Hemostatic Agent Emicizumab for Major Surgery in Hemophilia A: An Experience in Neurosurgery for an Infant

Authored by

Malavika Prakash P
Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.

Nimsha Rajesh
Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.

Narmadha MP
Department of Pharmacy Practice, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.

Suhas Udayakumaran
Division of Paediatric Neurosurgery and Craniofacial Surgery, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.

Rema G
Department of Clinical Haematology, Amrita Institute of Medical Sciences, Amrita Vishwa Vidyapeetham, Kochi, Kerala, India.

DOI or Article Link

https://doi.org/10.9734/ahrj/2025/v8i3202

Leave a Comment